Lansoprazole 45802-0878
Product NDC
45802-0878- Manufacturer
- Padagis Israel Pharmaceuticals Ltd
- Dosage Form
- Capsule, Delayed Release
- Route
- Oral
- Product Type
- Human Otc Drug
- Marketing Start
- July 29, 2021
- Listing Expires
- December 31, 2026
- Application
- ANDA202319
Active Ingredients
| Ingredient | Strength |
|---|---|
| Lansoprazole | 15 mg/1 |
Drug Class
Proton Pump Inhibitor [EPC]Inhibition Gastric Acid Secretion [PE]Proton Pump Inhibitor [EPC]
Packaging Options(3)
1 BOTTLE in 1 CARTON (45802-878-01) / 14 CAPSULE, DELAYED RELEASE in 1 BOTTLE
2 BOTTLE in 1 CARTON (45802-878-02) / 14 CAPSULE, DELAYED RELEASE in 1 BOTTLE
3 BOTTLE in 1 CARTON (45802-878-03) / 14 CAPSULE, DELAYED RELEASE in 1 BOTTLE